AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93020C00037INTRAVACC B.V.
Overview
Award facts
- Net obligations
- $9.04M
- $9,042,149of $9.26M potential value
- Outlays (paid to date)
- $7.50M
- $7.50M paid of $9.04M obligated$7,500,401
- Period of performance
- Sep 1, 2020 to May 31, 2026
- Ended
- Modifications
- 15
- Latest action Aug 20, 2026
- Contract type
- Definitive contract
- PIID 75N93020C00037
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TO DEVELOP AN INTRAMUSCULAR INACTIVATED WHOLE VIRUS VACCINE FROM EARLY PRODUCT SELECTION THROUGH A PHASE I CLINICAL TRIAL TO INDUCE PROTECTION AGAINST EV D68 INDUCED AFM.
Dates and value
- Award date
- Signed on Aug 20, 2020
- Current value
- $9,042,149Base and exercised options
- Potential value (if all options are exercised)
- $9,261,662
Obligations by fiscal year of action
- FY2026: -$964,757 (de-obligation)
- FY2025: $858,017
- FY2023: $1,085,889
- FY2022: $194,459
- FY2021: $5,031,575
- FY2020: $2,836,966
Total across 6 fiscal years: $9,042,149
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 20, 2026. View on USAspending · Recipient on SAM.gov
Recipient
NameINTRAVACC B.V.
LocationBILTHOVEN, UTRECHT, NLD
UEIRY3NEWMNZA63
CAGE codeH2MN6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyINTRAVACC B.V.
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Netherlands
Classification and competition
Classification
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- HHS-NIH-NIAID-BAA2020-1
- Solicitation date
- Jan 3, 2020
- Notices
- Award Notice posted May 12, 2021
- Award Notice posted May 12, 2021
- Award Notice posted Mar 16, 2021
- Award Notice posted Mar 16, 2021
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 28, 2020
- Award Notice posted Aug 21, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 20, 2020Base obligation at award: $2,836,966
- Latest action
- Aug 20, 2026 — Funding onlyModification P00015; obligation change -$964,757; funding only: changes obligations, not scope
- Latest substantive action
- Jul 3, 2023 — Option exercisedModification P00008; obligation change +$1,085,889
- Latest funding action
- Aug 20, 2026 — Funding onlyModification P00015; obligation change -$964,757; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action8
- Funding only3
- Option exercised3
- Novation (contract transferred)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$964,757
- Latest action: change in base and all options
- -$964,757
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- NetherlandsNLD
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 16
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2020-0885-000
- 075-2021/2021-0885-000
- 075-2022/2022-0885-000
- 075-2023/2023-0885-000
- 075-2025/2025-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression